|This article is an orphan, as no other articles link to it. (February 2009)|
Proteogenix is a corporation based in Portland, Oregon, United States, that develops and markets biomarker diagnostic tests for the detection of life-threatening pregnancy-related conditions. Proteogenix is currently developing non-invasive protein biomarker screening tests for intra-amniotic infection, premature birth, and Down syndrome, which combined cause 175,000 premature births each year in the United States alone.
Proteogenix has gained negative publicity through their use of unsolicited commercial email (spam).
- "ProteoGenix News from The BioSpace Beat". Biospace.com. September 29, 2004.
- . Mainsleaze.spambouncer.org. February 21, 2013 http://mainsleaze.spambouncer.org/?p=2943. Unknown parameter
|title=suggested) (help); Missing or empty